Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Phase 3 Study of Xelox(Capecitabine Plus Oxaliplatin) Followed by Maintenance Capecitabine or Observation in Patients With Advanced Gastric Adenocarcinoma

NCT02289547 is registered in ClinicalTrials.gov with The Catholic University of Korea as lead sponsor.

NCT NCT02289547
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02289547 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Phase 3 Study of Xelox(Capecitabine Plus Oxaliplatin) Followed by Maintenance Capecitabine or Observation in Patients With Advanced Gastric Adenocarcinoma
Lead sponsor
The Catholic University of Korea
Phase
Phase 3
Overall status
Unknown status
Start date
May 31, 2015
Completion date
January 31, 2019
Enrollment
184 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

stomach neoplasms